+ All Categories
Home > clin orthop relat
Management of Flatfoot
Management of Flatfoot
131 views
Antoni Morral: Professor of Physical Therapy. School of Health Science Blanquerna, Universitat Ramon Llull, Barcelona, Spain.
Antoni Morral: Professor of Physical Therapy. School of Health Science Blanquerna, Universitat Ramon Llull, Barcelona, Spain.
397 views
Pediatric Ankle & Foot Fractures Steven Rabin, MD Revised: March 2011 Original authors (2004): Laura Phieffer, MD & Steven Frick, MD Revised (2006): Steven.
Pediatric Ankle & Foot Fractures Steven Rabin, MD Revised: March 2011 Original authors (2004): Laura Phieffer, MD & Steven Frick, MD Revised (2006): Steven.
215 views
Fractures and Dislocations about the Hip in the Pediatric Patient Joshua Klatt, MD Original Author: Mark Tenholder, MD; March 2004 Revised: Steven Frick,
Fractures and Dislocations about the Hip in the Pediatric Patient Joshua Klatt, MD Original Author: Mark Tenholder, MD; March 2004 Revised: Steven Frick,
246 views
Results of Humeral Lengthening With Unilateral External Fixator.
Results of Humeral Lengthening With Unilateral External Fixator.
220 views
Should ESR and CRP be Included in the Routine Preoperative Workup for Primary Total Knee Arthroplasty? Dale T. Landry Jr., MD Vinod Dasa, MD.
Should ESR and CRP be Included in the Routine Preoperative Workup for Primary Total Knee Arthroplasty? Dale T. Landry Jr., MD Vinod Dasa, MD.
215 views
Anticoagulation in the Geriatric Patient: Detailed Issues in the Perioperative Period Susan M. Friedman, MD, MPH June 6, 2009 THE AMERICAN GERIATRICS SOCIETY.
Anticoagulation in the Geriatric Patient: Detailed Issues in the Perioperative Period Susan M. Friedman, MD, MPH June 6, 2009 THE AMERICAN GERIATRICS SOCIETY.
219 views
Three different cruciate sacrificing TKA designs: no intraoperative kinematic differences and no clinical differences at 2 years follow up. Bruni D, Bignozzi.
Three different cruciate sacrificing TKA designs: no intraoperative kinematic differences and no clinical differences at 2 years follow up. Bruni D, Bignozzi.
214 views
D.Bruni, MD; L.Bragonzoni, PhD; M.Gagliardi, MD; M.Bontempi, PhD; Akkawi I, MD; G.Raspugli,MD, Tedi M, MD; S.Patella, MD; Prof. M.Marcacci, MD. Rizzoli.
D.Bruni, MD; L.Bragonzoni, PhD; M.Gagliardi, MD; M.Bontempi, PhD; Akkawi I, MD; G.Raspugli,MD, Tedi M, MD; S.Patella, MD; Prof. M.Marcacci, MD. Rizzoli.
227 views
MEDICOLEGAL NOTHING TO DISCLOSE. BAGNALL’S MAXIM POWERPOINT IS THE VIAGRA OF PUBLIC SPEAKING DISCLOSURE: I HAVE NO INTEREST, WHATSOEVER, IN VIAGRA……….EVER!!
MEDICOLEGAL NOTHING TO DISCLOSE. BAGNALL’S MAXIM POWERPOINT IS THE VIAGRA OF PUBLIC SPEAKING DISCLOSURE: I HAVE NO INTEREST, WHATSOEVER, IN VIAGRA……….EVER!!
214 views
ALLONGEMENT DES MI METHODE DILIZAROV: quelles difficultés? 25ème Congrès National :27 au 30 mai 2009.
ALLONGEMENT DES MI METHODE DILIZAROV: quelles difficultés? 25ème Congrès National :27 au 30 mai 2009.
104 views
Ramesh Sen AVN
Ramesh Sen AVN
2.412 views